How can I treat enlarged facial pores without microneedling, using only ReDLE 100 (100 mg/mL hyaluronic‑acid filler) injections and a topical skincare regimen?

Treatment of Enlarged Facial Pores Without Microneedling

For enlarged facial pores when microneedling is unavailable, intradermal hyaluronic acid injection (such as ReDLE 100) combined with a comprehensive topical skincare regimen represents an effective evidence-based approach, with clinical studies demonstrating approximately 40% improvement in pore size. 1

Intradermal Hyaluronic Acid Injection Protocol

Treatment Parameters

• Dosing: Use 2.5 mL (25 mg) of low molecular weight hyaluronic acid per full-face treatment session 1
• Injection technique: Perform precise intradermal injections using a 30-gauge, 4 mm needle, spacing injections approximately 5 mm apart 2
• Depth: Inject into the intradermal layer, forming visible papules with blanching to confirm proper placement 2
• Treatment frequency: Repeat treatments 2-5 times with 1 to 1.5 month intervals between sessions 1
• Maintenance: Follow-up every 6-12 months after initial treatment series 2

Expected Outcomes

Clinical studies demonstrate a 40.03% ± 18.41% improvement rate in pore size with intradermal hyaluronic acid injection, with 92.8% overall patient satisfaction 1. The treatment significantly improves skin texture, reduces pore size, and enhances skin radiance 1.

Safety Profile

No infections, nodules, or pigmentation have been reported at injection sites in clinical studies 1. The technique is simple, safe, and effective for clinical practice 1.

Topical Skincare Regimen

Core Topical Agents

Retinoids (First-Line)

• Prescription options: Tretinoin (0.025-0.1%), adapalene (0.1%, 0.3%), or tazarotene (0.05%, 0.1%) 2
• Mechanism: Retinoids are comedolytic, resolve microcomedone lesions, and provide anti-inflammatory effects—making them the core of topical therapy 2
• Application: Use nightly, starting with lower concentrations to build tolerance 2

Azelaic Acid

• Concentration: 20% formulation 2
• Benefits: Mildly comedolytic, antibacterial, anti-inflammatory, and particularly useful for post-inflammatory dyspigmentation 2
• Pregnancy category: Category B, making it safer for reproductive-age women 2

Benzoyl Peroxide

• Role: Antibacterial properties help address sebum-related pore enlargement 2
• Combination therapy: Can be used with retinoids for enhanced efficacy 2

Treatment Strategy

Combination therapy should be used in the majority of patients, as using multiple topical agents that affect different aspects of pathogenesis is more effective than monotherapy 2. For enlarged pores specifically, the focus should be on controlling sebum production in younger patients, while older patients require both sebum control and rejuvenation approaches 3.

Post-Injection Topical Enhancement

Hyaluronic Acid Serum Application

After intradermal HA injection, apply topical crosslinked hyaluronic acid serum (RHA serum) twice daily starting 2 days post-procedure 4. This enhances:

• Skin surface topography and hydration 4
• Moisture, tone/complexion, radiance, texture, and uniformity 4
• Biomechanical properties and clinical appearance 4

The combination of intradermal HA injection with topical HA serum provides synergistic multi-level treatment 4.

Critical Considerations and Pitfalls

What to Avoid

• Do NOT apply topical retinoids immediately before or after HA injections to avoid excessive irritation 5
• Avoid sunlight and heavily scented facial products for 24 hours post-injection 2, 5
• Do NOT use topical antibiotics (clindamycin, erythromycin) during active injection procedures 5

Realistic Expectations

While intradermal HA injection shows significant improvement, multiple sessions and combination therapies are necessary to achieve optimal reduction in pore size and number 3. The multifactorial nature of enlarged pores (sebum production, aging, UV exposure) requires addressing multiple pathogenic factors simultaneously 6, 3.

Age-Specific Approach

• Younger patients: Prioritize sebum control with retinoids and azelaic acid 3
• Older patients: Combine sebum control with rejuvenation strategies using HA injections and topical HA serums 3

Alternative Considerations

If ReDLE 100 specifically refers to a different formulation than standard low molecular weight HA, the same intradermal injection principles apply, though non-cross-linked HA gel has demonstrated 83.20% composite improvement rates for skin quality with sustained 6-month benefits 7. The key is ensuring proper intradermal placement and adequate treatment frequency 1, 7.